CRISPR Therapeutics AG
USD56.35
+1.43 (+2.60%)
CEO
Samarth Kulkarni
IPO Date
2016-10-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CH
Open
$55.06
Prev. Close
$54.92
Day Low
$53.77
Day High
$57.80
52W Low
$44.12
52W High
$78.48
Market Cap
$5.43B
Volume
1.81M
| -9.1 |
| 31 Dec 2023 | FY | 64.8% | -41.5% | -8.2% | -6.9% | 0.13 | 17.54 | -32.3 |
| 31 Dec 2022 | FY | -25186.7% | -149122.7% | -34.7% | -29.0% | 0.13 | 15.30 | -4.9 |
| 31 Dec 2021 | FY | 88.9% | 41.4% | 15.7% | 13.7% | 0.09 | 20.17 | 15.2 |
| 31 Dec 2020 | FY | -37369.7% | -48520.9% | -21.0% | -19.1% | 0.04 | 18.21 | -28.9 |
| 31 Dec 2019 | FY | 38.1% | 23.1% | 7.1% | 6.3% | 0.06 | 17.29 | 49.5 |
| 31 Dec 2018 | FY | -3541.9% | -5281.1% | -42.1% | -33.7% | 0.00 | 16.81 | -8.3 |
| 31 Dec 2017 | FY | -70.3% | -166.7% | -36.4% | -25.2% | 0.00 | 17.12 | -13.7 |
| 31 Dec 2016 | FY | -717.9% | -449.3% | -10.0% | -6.7% | 0.00 | 14.56 | -10.7 |
| -9.0 |
| 30 Sept 2025 | Q3 | -7177.1% | -11973.1% | -5.6% | -4.7% | 0.21 | 16.22 | -13.9 |
| 30 Jun 2025 | Q2 | -5477.7% | -23379.9% | -12.2% | -10.3% | 0.13 | 16.61 | -5.1 |
| 31 Mar 2025 | Q1 | -6548.4% | -15722.1% | -7.4% | -6.3% | 0.12 | 15.64 | -5.4 |
| 31 Dec 2024 | Q4 | 100.0% | -106.6% | -1.9% | -1.7% | 0.12 | 22.07 | -22.5 |
| 30 Sept 2024 | Q3 | -2550.0% | -14276.1% | -4.4% | -3.8% | 0.12 | 21.64 | -11.6 |
| 30 Jun 2024 | Q2 | -10920.5% | -24450.3% | -6.4% | -5.4% | 0.12 | 15.73 | -9.1 |
| 31 Mar 2024 | Q1 | -10177.6% | -23133.1% | -5.6% | -4.8% | 0.11 | 17.81 | -12.0 |
| 31 Dec 2023 | Q4 | 90.0% | 44.7% | 4.7% | 4.0% | 0.13 | 17.54 | 14.0 |